Intravitreal aflibercept injection for neovascular age-related macular degeneration: Ninety-six-week results of the VIEW studies

Intravitreal aflibercept injection for neovascular age-related macular degeneration: Ninety-six-week results of the VIEW studies

Show other versions (1)

Purpose To determine efficacy and safety of intravitreal aflibercept in patients with neovascular age-related macular degeneration (AMD) during a second year of variable dosing after a first-year fixed-dosing period. Design Two randomized, double-masked, active-controlled, phase 3 trials. Participan...

Full description

Bibliographic Details
Main Authors: Schmidt-Erfurth, U, Kaiser, P, Korobelnik, J, Brown, D, Chong, V, Nguyen, Q, Ho, A, Ogura, Y, Simader, C, Jaffe, G, Slakter, J, Yancopoulos, G, Stahl, N, Vitti, R, Berliner, A, Soo, Y, Anderesi, M, Sowade, O, Zeitz, O, Norenberg, C, Sandbrink, R, Heier, J
Format: Conference item
Published: 2014

Similar Items